9 results
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
8:41am
for patients; diversity; and governance.
Over the last 25 years, our Biologics team has developed into a fully integrated organization with robust
6-K/A
EX-99.1
ALVO
Alvotech
7 Sep 23
Current report (foreign) (amended)
1:06pm
and decommissioning obligations, with a focus on reducing diversity in practice. The amendments narrow the scope of the initial recognition exemption
6-K
EX-99.1
ALVO
Alvotech
31 Aug 23
Current report (foreign)
8:00am
and decommissioning obligations, with a focus on reducing diversity in practice. The amendments narrow the scope of the initial recognition exemption
424B3
ALVO
Alvotech
1 Dec 22
Prospectus supplement
5:27pm
. Fridriksdottir holds a PhD in Physical Pharmacy from the University of Iceland. She has been a strong advocate for diversity and equal opportunity in pharma
424B3
nr4qnp9jzn7e1sa ef
1 Dec 22
Prospectus supplement
5:25pm
6-K
EX-99.2
12a3gzbk
1 Dec 22
Alvotech submits its application for admission of the company’s shares to trading on Nasdaq Iceland Main Market
5:20pm
6-K
EX-99.3
nkx3phxj 3d9
31 Aug 22
Current report (foreign)
5:23pm
6-K
EX-99.1
6pl5jq832 b7xr
29 Aug 22
Alvotech Announces Corporate Sustainability Participation and Discloses ESG Data covering 2020 and 2021
6:06am
- Prev
- 1
- Next